BridgeBio ( BBIO) rose 2.9% after a court filing appeared to indicate a settlement in a generic patent case over Pfizer's ( ...

TRENTON, N.J.-The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales ...

Pfizer has reached an agreement with generic manufacturer Dexcel to end a key patent lawsuit over its Vyndamax heart drug, while European regulators recommended three major therapies from Sanofi, ...

The US Food and Drug Administration (FDA) on Friday approved the first generic versions of Pfizer’s blockbuster pain drug Lyrica (pregabalin). The approvals were granted to Alembic Pharmaceuticals, ...

Pfizer’s recent positive data for atirmociclib, tilrekimig, Padcev, and the Lyme disease vaccine candidate highlight pipeline ...

Pfizer Inc. has recently seen how sales of its biggest-selling drug, anti-cholesterol medication Lipitor, started falling when it had to compete with cheaper generic versions. The pharmaceutical giant ...

Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection. Many media outlets were impressed with Pfizer’s aggressive, ...

When seven biopharma executives were asked by senators in February whether they had intentionally blocked generic competition, all of them said no. But several of the companies’ products were included ...

Recently, President Trump signed a “most-favored nation” executive order on drug prices with a claim that it would force pharmaceutical companies to lower U.S. prescription costs to match those abroad ...